Antibiotics before endoscopy: necessary or not for cirrhosis patients?
NCT ID NCT06437964
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looked at whether giving antibiotics before an endoscopic procedure helps prevent fever and rebleeding in people with cirrhosis who have had variceal bleeding before. 226 patients were randomly assigned to receive the antibiotic ceftriaxone or no antibiotics before the procedure. The goal was to see if skipping antibiotics is just as safe (non-inferior) as using them.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- ceftriaxone (an antibiotic)
- What this could lead to
- If successful, this could show that skipping antibiotics before endoscopy is safe for some cirrhosis patients, reducing unnecessary drug use.
- What could go wrong
- This is a small, completed trial with only 226 participants. Results may not apply to all patients, and skipping antibiotics could raise infection risk.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CIRRHOSIS, LIVER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The 2nd Affiliated Hospital, School of Medicine, Zhejiang University, China
Hangzhou, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A new procedure may offer relief for Cirrhosis-Related fluid buildup
- Early liver shunt may reduce need for repeated fluid drains in ascites patients
- Decade-Long study aims to unlock liver disease risks in HIV-Hepatitis b patients
- Zambia study tracks hepatitis b outcomes in hundreds of patients
- New study tracks blood sugar in liver disease patients on common drug
- New drug aims to stop liver failure in NASH patients